Work

Viral Decay Dynamics in HIV‐Infected Patients Receiving Ritonavir‐Boosted Saquinavir and Efavirenz With or Without Enfuvirtide: A Randomized, Controlled Trial (HIV‐NAT 012)

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Journal of Infectious Diseases

DOI: 10.1086/508291

Authors: Mark A. Boyd, Narendra M. Dixit, Umaporn Siangphoe, Neil E. Buss, Miklos P. Salgo, Joep M. A. Lange, Praphan Phanuphak, David A. Cooper, Alan S. Perelson, Kiat Ruxrungtham

Institutions: Flinders University, Flinders Medical Centre, UNSW Sydney, HIV Netherlands Australia Thailand Research Collaboration, Indian Institute of Science Bangalore, F. Hoffmann-La Roche AG, Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Chulalongkorn University, Los Alamos National Laboratory

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institute of Allergy and Infectious Diseases, National Center for Research Resources

Awards: Immune System Modeling/HIV, Modeling Viral and T Lymphocyte Dynamics

OpenAlex ID: W2154520854

FWCI: 1.643

Cites: 17

Cited by: 13

Related to: 10